MEDICINA
DEPARTAMENTO
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (10)
2024
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422
2023
-
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
The Lancet Oncology, Vol. 24, Núm. 9, pp. 1029-1041
2022
-
ANTES Program: One Year on
Archivos de Bronconeumologia
-
The Effect of Clusters of Double Triggering and Ineffective Efforts in Critically Ill Patients
Critical Care Medicine, Vol. 50, Núm. 7, pp. E619-E629
-
[Translated article] ANTES Program: One Year on
Archivos de Bronconeumologia
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
-
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911
2015
-
Asynchronies during mechanical ventilation are associated with mortality
Intensive Care Medicine, Vol. 41, Núm. 4, pp. 633-641
2013
-
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
New England Journal of Medicine, Vol. 369, Núm. 14, pp. 1317-1326
2011
-
Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency
Calcified Tissue International, Vol. 88, Núm. 6, pp. 485-494